Results 71 to 80 of about 232,900 (410)

Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants [PDF]

open access: yes, 2014
Background & aims: Non-alcoholic fatty liver disease was traditionally interpreted as a condition which may progress to liver-related complications. However, the increased mortality is primarily a result of cardiovascular diseases.
ANGELICO, Francesco   +11 more
core   +1 more source

Pediatric Non-Alcoholic Fatty Liver Disease [PDF]

open access: yesChildren, 2017
Abstract: With the increase in the prevalence of obesity, non-alcoholic fatty liver disease (NAFLD) has become among the leading causes of chronic liver disease in the pediatric age group. Once believed to be a “two-hit process”, it is now clear that the actual pathophysiology of NAFLD is complex and involves multiple pathways.
Zobair M. Younossi   +3 more
openaire   +3 more sources

Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis

open access: yesBMC Endocrine Disorders, 2021
Background Non-alcoholic fatty liver disease (NAFLD) is a common disorder that is known to be the leading cause of chronic liver disease worldwide.
Nader Salari   +6 more
doaj   +1 more source

FibroScan and non-invasive indices for the diagnosis of non-alcoholic fatty liver disease [PDF]

open access: yes, 2017
Background. Non-alcoholic fatty liver disease (NAFLD), an independent nosological entity, is characterized by fat accumulation in hepatocytes not associated with alcohol abuse, and includes a wide spectrum of disorders: from fatty liver, non-alcoholic ...
Nedzvetskaya, N.V.   +4 more
core   +3 more sources

Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis. [PDF]

open access: yes, 2016
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in adults and children worldwide. NAFLD has become a severe health issue and it can progress towards a more severe form of the disease, the non-alcoholic ...
Feldstein, Ariel E, Povero, Davide
core   +2 more sources

Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease. [PDF]

open access: yesPLoS ONE, 2016
Although non-alcoholic and alcoholic fatty liver disease have been intensively studied, concerning pathophysiological mechanisms are still incompletely understood.
Vera H I Fengler   +10 more
doaj   +1 more source

Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study

open access: yesJournal of Nepal Medical Association, 2021
Introduction: Non-alcoholic fatty liver disease is fatty infiltration of the liver in the absence of other causes of steatosis. It is strongly associated with central adiposity, high body mass index, insulin resistance states, hypertension ...
Bom BC   +4 more
doaj   +1 more source

Liver Fibrosis and NAS scoring from CT images using self-supervised learning and texture encoding [PDF]

open access: yesarXiv, 2021
Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver diseases (CLD) which can progress to liver cancer. The severity and treatment of NAFLD is determined by NAFLD Activity Scores (NAS)and liver fibrosis stage, which are usually obtained from liver biopsy.
arxiv  

Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? [PDF]

open access: yes, 2014
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease that might affect up to one-third of the adult population in industrialised countries.
Firneisz, Gábor
core   +1 more source

Non-alcoholic fatty liver disease:mind the gaps: pathophysiology and non-invasive diagnosis [PDF]

open access: yes, 2021
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in western countries. Globally, NAFLD affects approximately 25% of the population. The term NAFLD includes both fatty liver disease (steatosis) and inflammation of the liver (NASH;
Verhaegh, Pauline Loraine Maria
core   +2 more sources

Home - About - Disclaimer - Privacy